US Stock MarketDetailed Quotes

Atrium Therapeutics (RNA)

Watchlist
  • 13.140
  • -0.110-0.83%
Close May 12 16:00 ET
  • 13.140
  • 0.0000.00%
Post 16:10 ET
203.87MMarket Cap-4.12P/E (TTM)

Atrium Therapeutics (RNA) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(FY)Dec 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments
--270M
--270M
--270M
----
----
----
-Cash and cash equivalents
--270M
--270M
--270M
----
----
----
Receivables
----
----
----
----
----
--751K
-Accounts receivable
----
----
----
----
----
--751K
Prepaid assets
217.81%1.54M
217.81%1.54M
--1.26M
360.00%483K
--483K
--105K
Other current assets
--1.31M
--1.31M
----
----
----
----
Total current assets
56,389.65%272.85M
56,389.65%272.85M
--271.26M
-43.57%483K
--483K
--856K
Non current assets
Net PPE
-17.83%5.51M
-17.83%5.51M
--6.28M
-28.97%6.7M
--6.7M
--9.44M
-Gross PPE
5.23%8.35M
5.23%8.35M
--7.69M
-23.11%7.94M
--7.94M
--10.32M
-Accumulated depreciation
-130.47%-2.84M
-130.47%-2.84M
---1.4M
-39.44%-1.23M
---1.23M
---885K
Total non current assets
-17.83%5.51M
-17.83%5.51M
--6.28M
-28.97%6.7M
--6.7M
--9.44M
Total assets
3,773.55%278.35M
3,773.55%278.35M
--277.54M
-30.19%7.19M
--7.19M
--10.29M
Liabilities
Current liabilities
Payables
726.69%4.4M
726.69%4.4M
--451K
6.83%532K
--532K
--498K
-accounts payable
726.69%4.4M
726.69%4.4M
--451K
6.83%532K
--532K
--498K
Current accrued expenses
649.79%8.95M
649.79%8.95M
--5.61M
82.14%1.19M
--1.19M
--655K
Current debt and capital lease obligation
-4.47%3.67M
-4.47%3.67M
--3.97M
5.63%3.84M
--3.84M
--3.64M
-Current capital lease obligation
-4.47%3.67M
-4.47%3.67M
--3.97M
5.63%3.84M
--3.84M
--3.64M
Current deferred liabilities
3.11%21.64M
3.11%21.64M
--19.12M
-25.47%20.99M
--20.99M
--28.16M
Current liabilities
55.96%41.8M
55.96%41.8M
--31.74M
-20.71%26.8M
--26.8M
--33.8M
Non current liabilities
Long term debt and capital lease obligation
----
----
--312K
-52.41%2.96M
--2.96M
--6.21M
-Long term capital lease obligation
----
----
--312K
-52.41%2.96M
--2.96M
--6.21M
Non current deferred liabilities
-24.42%28.69M
-24.42%28.69M
--32.07M
-7.18%37.96M
--37.96M
--40.9M
Other non current liabilities
0.00%574K
0.00%574K
--574K
--574K
--574K
----
Total non current liabilities
-29.47%29.27M
-29.47%29.27M
--32.95M
-11.93%41.49M
--41.49M
--47.11M
Total liabilities
4.06%71.07M
4.06%71.07M
--64.69M
-15.59%68.29M
--68.29M
--80.91M
Shareholders'equity
Share capital
--17K
--17K
--17K
----
----
----
-common stock
--17K
--17K
--17K
----
----
----
Paid-in capital
--207.27M
--207.27M
--212.84M
----
----
----
Other equity interest
----
----
----
13.47%-61.11M
---61.11M
---70.62M
Total stockholders'equity
439.21%207.29M
439.21%207.29M
--212.85M
13.47%-61.11M
---61.11M
---70.62M
Total equity
439.21%207.29M
439.21%207.29M
--212.85M
13.47%-61.11M
---61.11M
---70.62M
Currency Unit
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(FY)Dec 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments --270M--270M--270M------------
-Cash and cash equivalents --270M--270M--270M------------
Receivables ----------------------751K
-Accounts receivable ----------------------751K
Prepaid assets 217.81%1.54M217.81%1.54M--1.26M360.00%483K--483K--105K
Other current assets --1.31M--1.31M----------------
Total current assets 56,389.65%272.85M56,389.65%272.85M--271.26M-43.57%483K--483K--856K
Non current assets
Net PPE -17.83%5.51M-17.83%5.51M--6.28M-28.97%6.7M--6.7M--9.44M
-Gross PPE 5.23%8.35M5.23%8.35M--7.69M-23.11%7.94M--7.94M--10.32M
-Accumulated depreciation -130.47%-2.84M-130.47%-2.84M---1.4M-39.44%-1.23M---1.23M---885K
Total non current assets -17.83%5.51M-17.83%5.51M--6.28M-28.97%6.7M--6.7M--9.44M
Total assets 3,773.55%278.35M3,773.55%278.35M--277.54M-30.19%7.19M--7.19M--10.29M
Liabilities
Current liabilities
Payables 726.69%4.4M726.69%4.4M--451K6.83%532K--532K--498K
-accounts payable 726.69%4.4M726.69%4.4M--451K6.83%532K--532K--498K
Current accrued expenses 649.79%8.95M649.79%8.95M--5.61M82.14%1.19M--1.19M--655K
Current debt and capital lease obligation -4.47%3.67M-4.47%3.67M--3.97M5.63%3.84M--3.84M--3.64M
-Current capital lease obligation -4.47%3.67M-4.47%3.67M--3.97M5.63%3.84M--3.84M--3.64M
Current deferred liabilities 3.11%21.64M3.11%21.64M--19.12M-25.47%20.99M--20.99M--28.16M
Current liabilities 55.96%41.8M55.96%41.8M--31.74M-20.71%26.8M--26.8M--33.8M
Non current liabilities
Long term debt and capital lease obligation ----------312K-52.41%2.96M--2.96M--6.21M
-Long term capital lease obligation ----------312K-52.41%2.96M--2.96M--6.21M
Non current deferred liabilities -24.42%28.69M-24.42%28.69M--32.07M-7.18%37.96M--37.96M--40.9M
Other non current liabilities 0.00%574K0.00%574K--574K--574K--574K----
Total non current liabilities -29.47%29.27M-29.47%29.27M--32.95M-11.93%41.49M--41.49M--47.11M
Total liabilities 4.06%71.07M4.06%71.07M--64.69M-15.59%68.29M--68.29M--80.91M
Shareholders'equity
Share capital --17K--17K--17K------------
-common stock --17K--17K--17K------------
Paid-in capital --207.27M--207.27M--212.84M------------
Other equity interest ------------13.47%-61.11M---61.11M---70.62M
Total stockholders'equity 439.21%207.29M439.21%207.29M--212.85M13.47%-61.11M---61.11M---70.62M
Total equity 439.21%207.29M439.21%207.29M--212.85M13.47%-61.11M---61.11M---70.62M
Currency Unit USDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More